NCT03300830
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Castleman Disease, +30 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,947 public trials
2,015 recruiting studies
Immunoproliferative Disorders trial results
NCT07109219
- Conditions
- B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +19 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site Jacksonville, Florida, United States
- Research Site Chicago, Illinois, United States
- Research Site Iowa City, Iowa, United States
NCT06548152
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Research Site Saint-Affrique, France
NCT06644625
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- Atrium Health Levine Cancer Charlotte, North Carolina, United States
Recruiting
Myeloma Registry Platform (MYRIAM)
NCT03308474
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Multiple sites all over germany Multiple Sites, Germany
NCT05852717
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- University of Virginia Health System Charlottesville, Virginia, United States
NCT07194980
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
NCT06558604
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Az Sint-Jan Brugge - Oostende Av Bruges, Belgium
- Institut Jules Bordet Brussels, Belgium
- Chu de Liege Liège, Belgium
- Chu Ucl Namur - Site Godinne Yvoir, Belgium
NCT07308132
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Monash Medical Centre Clayton, Australia
- Peter MacCallum Cancer Centre Melbourne, Australia
- Macquarie University Hospital North Ryde, Australia
- Scientia Clinical Research Randwick, Australia
NCT05672251
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States